The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and a precursor condition, mild cognitive impairment.
Technology-assisted therapy for kids and young people is as effective as traditional face-to-face therapy
Using technology to deliver therapy for children and young people is as effective as traditional face-to-face therapy, according to new research.
July 13, 2024